Legal Representation
Attorney
Stewart J. Bellus
USPTO Deadlines
Next Renewal Deadline
386 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-28)
Due Date
July 28, 2026
Grace Period Ends
January 28, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description |
|---|---|---|---|
| May 27, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| May 14, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Apr 1, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Oct 27, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Jul 17, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Dec 6, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Nov 17, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Nov 17, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Oct 28, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jul 28, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| May 12, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 12, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 22, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 7, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 7, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 7, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 6, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Feb 18, 2020 | CNFR | R | FINAL REFUSAL WRITTEN |
| Feb 18, 2020 | GNFR | O | FINAL REFUSAL E-MAILED |
| Feb 18, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Feb 3, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 3, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 29, 2020 | ALIE | A | ASSIGNED TO LIE |
| Jan 23, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Dec 6, 2019 | RFNT | P | REFUSAL PROCESSED BY IB |
| Nov 19, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Nov 19, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Oct 29, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Oct 28, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 22, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 8, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Oct 3, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 27, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Sep 26, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Sodium hyaluronate for use in the manufacture of pharmaceuticals, cosmetics and nutritional supplements
First Use Anywhere:
0
First Use in Commerce:
0
Class 003
Cosmetics
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Sodium hyaluronate for medical purposes for wrinkle minimizing, reducing and removing sold in pre-filled disposable sterile syringes; sodium hyaluronate for medical purposes for tissue regeneration and for the treatment of abrasion and wound sold in pre-filled disposable sterile syringes; Sodium hyaluronate for medical purposes for the treatment of dry eyes in the form of eye drops; Sodium hyaluronate for medical purposes for the treatment of arthritis sold in pre-filled disposable sterile syringes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PRINCIP HYAL
Classification
International Classes
001
003
005